All lobbying filings

ARDELYX, INC.

Lobbying for ARDELYX, INC.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $650,000.00 expenses · posted Oct 8, 2025

Official filing document

Bills named in this filing 2

HR 5074
Protecting Young Minds Online Act
S 4510
Kidney PATIENT Act of 2024

Lobbying activity 1

Health Issues

Access to innovative kidney treatments. H.R.5074 - Protecting Young Minds Online Act, S.4510 - Kidney PATIENT Act of 2024. Pharmaceutical pricing proposals, Medicare pharmaceutical payment and access issues. Coverage of oral only End-Stage Renal Disease drugs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.